logo

Cesca Therapeutics Inc. (KOOL)



Trade KOOL now with
  Date
  Headline
10/22/2019 6:56:36 AM Cesca Therapeutics Enters Definitive JV Agreement With HealthBanks Biotech (USA) Inc.
9/9/2019 8:37:44 AM Cesca Therapeutics And ThermoGenesis Announce Distribution Agreement For X-Series Products
6/26/2019 8:36:59 AM Cesca Therapeutics Regains Nasdaq Listing Compliance
6/25/2019 8:31:45 AM Cordlife To Use ThermoGenesis AXP II System For Rapid Processing Of Cord Blood Units In India
6/18/2019 8:34:05 AM ThermoGenesis Gets Health Canada Approval Of Next-Generation AXP II System For Cord Blood Processing
6/4/2019 12:45:05 PM Cesca Therapeutics Announces 1-for-10 Reverse Split Of Common Stock
3/25/2019 4:06:42 PM Cesca Therapeutics FY18 Net Loss To Stockholders $39.72 Mln Vs. Loss $5.53 Mln Last Year
2/25/2019 8:02:49 AM ThermoGenesis Gets Health Canada Approval Of PXP System For Automated Processing Of Bone Marrow Cells
1/4/2019 8:35:54 AM Cesca Therapeutics Acquires Remaining Ownership Stake In ThermoGenesis
11/19/2018 10:00:18 AM Cesca Receives 510(k) Clearance To Market AXP II AutoXpress Platform For Clinical Cord Blood Banking
10/16/2018 8:35:49 AM Cesca Therapeutics Announces Departure Of Vivian Liu, COO, And Joseph Balagot, SVP Of Corporate Development
5/18/2018 11:37:33 AM Cesca Announces Closing Of $5.5 Mln Public Offering
5/16/2018 1:19:06 PM Cesca Prices $5.5 Mln Public Offering
3/28/2018 7:10:11 AM Cesca Therapeutics Announces Two Abstracts Accepted For Poster Presentation At ISCT 2018 Annual Meeting